Finanzen von CNO Financial Group Inc (CNO)CNOCNO Financial Group Inc

CNO Financial Group, Inc. (CNO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Health, accounting for 49.2% of total sales, equivalent to $506.50M. Other significant revenue streams include Life and Annuity. Understanding this composition is critical for investors evaluating how CNO navigates market cycles within the Life & Health Insurance industry.

Evaluating the bottom line, CNO Financial Group, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 16.64%, while the net margin is 9.73%. These profitability ratios, combined with a Return on Equity (ROE) of 10.93%, provide a clear picture of how effectively CNO converts its operational activities into shareholder value.

In the context of the broader market, CNO competes directly with industry leaders such as WTM and RLI. With a market capitalization of $5.10B, it holds a significant position in the sector. When comparing efficiency, CNO's gross margin of N/A stands against WTM's N/A and RLI's N/A. Such benchmarking helps identify whether CNO Financial Group, Inc. is trading at a premium or discount relative to its financial performance.

CNO Financial has shown strong financial performance with a 31.21% year-to-date change and a 41.47% increase over the past year. The company has consistently achieved sales growth, with new annualized premiums up 7% and a significant 52% increase in Medicare Supplement premiums in Q2 2026.